ANTX- An2 Therapeutics, Inc.

Name: An2 Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

An2 Therapeutics, Inc. (ANTX) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 29 sells. ANTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Eizen Joshua M	92.0K	$484.8K	-
Dir	Marks Gilbert Lynn	79.1K	$416.8K	-
Other	Williams Sarah Joanne	66.6K	$350.9K	-265
Other	Prior Stephen David	59.1K	$311.4K	-
Other	Chanda Sanjay	58.0K	$305.4K	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 2, 2024	Easom Eric74	Chief Executive Officer	Sell	2,777	$20.09	$55,802.43	-56.6%	-81.1%	-93.0%
Nov 14, 2023	Adjuvant Global Health Technology Fund, L.P.73	10% Owner	Sell	1,810	$16.15	$29,224.26	-	-68.0%	-93.7%
Nov 14, 2023	Aziz Kabeer73	Director, 10% Owner	Sell	1,810	$16.15	$29,224.26	-	-68.0%	-93.7%
Oct 2, 2023	Aziz Kabeer73	Director, 10% Owner	Sell	104,773	$16.27	$1,704,513.32	-2.1%	+28.1%	-93.2%
Oct 2, 2023	Adjuvant Global Health Technology Fund, L.P.73	10% Owner	Sell	104,773	$16.27	$1,704,513.32	-2.1%	+28.1%	-93.2%
Sep 28, 2023	Adjuvant Global Health Technology Fund, L.P.73	10% Owner	Sell	9,357	$16.11	$150,707.63	-0.2%	+31.6%	-93.4%
Sep 28, 2023	Aziz Kabeer73	Director, 10% Owner	Sell	9,357	$16.11	$150,707.63	-0.2%	+31.6%	-93.4%
Sep 13, 2023	Aziz Kabeer73	Director, 10% Owner	Sell	400	$16.00	$6,400.00	-	+36.5%	-93.0%
Sep 13, 2023	Adjuvant Global Health Technology Fund, L.P.73	10% Owner	Sell	400	$16.00	$6,400.00	-	+36.5%	-93.0%
Sep 7, 2023	Aziz Kabeer73	Director, 10% Owner	Sell	7,140	$16.03	$114,484.14	-0.1%	+24.4%	-93.4%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC